357 related articles for article (PubMed ID: 29480816)
1. Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes.
Ullah I; Karthik GM; Alkodsi A; Kjällquist U; Stålhammar G; Lövrot J; Martinez NF; Lagergren J; Hautaniemi S; Hartman J; Bergh J
J Clin Invest; 2018 Apr; 128(4):1355-1370. PubMed ID: 29480816
[TBL] [Abstract][Full Text] [Related]
2. Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome.
Venet D; Fimereli D; Rothé F; Boeckx B; Maetens M; Majjaj S; Rouas G; Capra M; Bonizzi G; Contaldo F; Galant C; Piccart M; Pruneri G; Larsimont D; Lambrechts D; Desmedt C; Sotiriou C
EBioMedicine; 2020 Jun; 56():102793. PubMed ID: 32512508
[TBL] [Abstract][Full Text] [Related]
3. HER2 expression in fine needle aspirates of lymph nodes detected by preoperative axillary ultrasound in breast cancer patients.
Choi JS; Kim HO; Kim EK; Suh YJ; Yoon JH; Moon HJ; Kim MJ
PLoS One; 2014; 9(11):e113065. PubMed ID: 25393693
[TBL] [Abstract][Full Text] [Related]
4. The Spatiotemporal Evolution of Lymph Node Spread in Early Breast Cancer.
Barry P; Vatsiou A; Spiteri I; Nichol D; Cresswell GD; Acar A; Trahearn N; Hrebien S; Garcia-Murillas I; Chkhaidze K; Ermini L; Huntingford IS; Cottom H; Zabaglo L; Koelble K; Khalique S; Rusby JE; Muscara F; Dowsett M; Maley CC; Natrajan R; Yuan Y; Schiavon G; Turner N; Sottoriva A
Clin Cancer Res; 2018 Oct; 24(19):4763-4770. PubMed ID: 29891724
[No Abstract] [Full Text] [Related]
5. The genomic heritage of lymph node metastases: implications for clinical management of patients with breast cancer.
Becker TE; Ellsworth RE; Deyarmin B; Patney HL; Jordan RM; Hooke JA; Shriver CD; Ellsworth DL
Ann Surg Oncol; 2008 Apr; 15(4):1056-63. PubMed ID: 18246400
[TBL] [Abstract][Full Text] [Related]
6. Multi-regional sequencing reveals clonal and polyclonal seeding from primary tumor to metastases in advanced gastric cancer.
Hirotsu Y; Hada M; Amemiya K; Oyama T; Mochizuki H; Omata M
J Gastroenterol; 2020 May; 55(5):553-564. PubMed ID: 31912238
[TBL] [Abstract][Full Text] [Related]
7. Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis.
Wei Q; Ye Z; Zhong X; Li L; Wang C; Myers RE; Palazzo JP; Fortuna D; Yan A; Waldman SA; Chen X; Posey JA; Basu-Mallick A; Jiang BH; Hou L; Shu J; Sun Y; Xing J; Li B; Yang H
Ann Oncol; 2017 Sep; 28(9):2135-2141. PubMed ID: 28911083
[TBL] [Abstract][Full Text] [Related]
8. Coexisting genomic aberrations associated with lymph node metastasis in breast cancer.
Bao L; Qian Z; Lyng MB; Wang L; Yu Y; Wang T; Zhang X; Yang H; Brünner N; Wang J; Ditzel HJ
J Clin Invest; 2018 Jun; 128(6):2310-2324. PubMed ID: 29558370
[TBL] [Abstract][Full Text] [Related]
9. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
10. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes.
Rouzier R; Extra JM; Klijanienko J; Falcou MC; Asselain B; Vincent-Salomon A; Vielh P; Bourstyn E
J Clin Oncol; 2002 Mar; 20(5):1304-10. PubMed ID: 11870173
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
12. Isolated Contralateral Axillary Lymph Node Involvement in Breast Cancer Represents a Locally Advanced Disease Not Distant Metastases.
Chkheidze R; Sanders MAG; Haley B; Leitch AM; Sahoo S
Clin Breast Cancer; 2018 Aug; 18(4):298-304. PubMed ID: 29233470
[TBL] [Abstract][Full Text] [Related]
13. Rare subclonal sequencing of breast cancers indicates putative metastatic driver mutations are predominately acquired after dissemination.
Lawrence-Paul MR; Pan TC; Pant DK; Shih NNC; Chen Y; Belka GK; Feldman M; DeMichele A; Chodosh LA
Genome Med; 2024 Feb; 16(1):26. PubMed ID: 38321573
[TBL] [Abstract][Full Text] [Related]
14. Genomic characterization of metastatic breast cancers.
Bertucci F; Ng CKY; Patsouris A; Droin N; Piscuoglio S; Carbuccia N; Soria JC; Dien AT; Adnani Y; Kamal M; Garnier S; Meurice G; Jimenez M; Dogan S; Verret B; Chaffanet M; Bachelot T; Campone M; Lefeuvre C; Bonnefoi H; Dalenc F; Jacquet A; De Filippo MR; Babbar N; Birnbaum D; Filleron T; Le Tourneau C; André F
Nature; 2019 May; 569(7757):560-564. PubMed ID: 31118521
[TBL] [Abstract][Full Text] [Related]
15. Axillary lymph drainage as a prognostic factor of survival in breast cancer.
Kett K; Szilágyi K; Anga B; Kett AG; Királyfalvi K
Lymphology; 2002 Dec; 35(4):161-70. PubMed ID: 12570325
[TBL] [Abstract][Full Text] [Related]
16. [Correlation between extranodal invasion in axillary lymph node metastasis and prognosis of breast cancer patients].
Zhang LL; Ma L; Geng CZ; Jia Y; Wang XL; Liu YP
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):525-529. PubMed ID: 28810291
[No Abstract] [Full Text] [Related]
17. Therapeutic role of axillary lymph node dissection in patients with stage IV breast cancer: a population-based analysis.
Wu SG; Li FY; Chen Y; Sun JY; Lin HX; Lin Q; He ZY
J Cancer Res Clin Oncol; 2017 Mar; 143(3):467-474. PubMed ID: 27812853
[TBL] [Abstract][Full Text] [Related]
18. Impact of preoperative ultrasonography and fine-needle aspiration of axillary lymph nodes on surgical management of primary breast cancer.
Park SH; Kim MJ; Park BW; Moon HJ; Kwak JY; Kim EK
Ann Surg Oncol; 2011 Mar; 18(3):738-44. PubMed ID: 20890729
[TBL] [Abstract][Full Text] [Related]
19. Specific upregulation of RHOA and RAC1 in cancer-associated fibroblasts found at primary tumor and lymph node metastatic sites in breast cancer.
Rozenchan PB; Pasini FS; Roela RA; Katayama ML; Mundim FG; Brentani H; Lyra EC; Brentani MM
Tumour Biol; 2015 Dec; 36(12):9589-97. PubMed ID: 26142737
[TBL] [Abstract][Full Text] [Related]
20. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
